Maker of Sexual Desire Drug Addyi Gets FDA Warning Letter

(MedPage Today) — Sprout Pharmaceuticals failed to include drug risk information in a promotional social media post, the FDA said in a warning letter posted on Tuesday.
The agency said the company’s CEO Cindy Eckert included a “false or misleading…